The BMC Medicine study confirms that adhering to the 2018 World Cancer Research Fund/American Institute for Cancer Research recommendations significantly lowers the risk of various cancers, including breast, colorectal, and esophageal, in the UK population. This highlights the importance of lifestyle choices in cancer prevention.
Formycon announces EMA submission for FYB203, a biosimilar candidate to Eylea® (Aflibercept) – Biotech Investments
EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon announces EMA submission for FYB203, a biosimilar candidate to Eylea® (Aflibercept) 27.11.2023 / 07:30 CET/CEST The